USA AKTIER - Diskussion och forum Shareville

2021-03-30 · Oncotelic Therapeutics, Inc. (f/k/a Mateon Therapeutics, Inc.) (“Oncotelic”), was formed in the State of New York in 1988 as OXiGENE, Inc., was reincorporated in the State of Delaware in 1992 Mateon has three major business segments: 1) PointR- developer of vision grid/cluster computing/AI to support drug development. 2) Mateon/Oxigene- developer of Vascular Disrupting Agent (CA4P and Oxi4503). FDA granted CA4P rare pediatric designation for pediatric melanoma in 2020 and OXi4503 rare pediatric designation for pediatric ALL. PLRX.O Pliant Therapeutics Inc $24.52 870 576 NMF 43.97 ALBO.O Albireo Pharma Inc $36.98 705 427 44.50 28.40 RIGL.O Rigel Pharmaceuticals Inc $3.47 586 533 5.86 5.57 SPPI.O Spectrum Pharmaceuticals Inc $3.46 505 307 8.96 6.14 AVERAGE 31.67 28.85 MATN.PK Mateon Therapeutics Inc $0.22 20 21 7.83 8.58 MATN Discount to Peers -75% -70% : Mateon was created by the recent reverse merger with Oncotelic, Inc., which became a wholly owned subsidiary of Mateon, thereby creating an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. lll Nachrichten zu Mateon Therapeutics Mateon Therapeutics Aktie.

Mateon therapeutics aktie

Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid. Visa MATEON THERAPEUTICS INC-diagram live för att se aktiens kursutveckling. Hitta marknadsprognoser MATN aktiediagram. Interaktivt diagram.

Börsen idag - Keskusteluryhmä Shareville

Diesen Artikel teilen. Wertpapier.

Moderna therapeutics aktie - Abogadoluisaltuna.es

27.07.2020 - AGOURA HILLS, California, July 27, 2020 (GLOBE NEWSWIRE) - Mateon Therapeutics (OTC.QB: MATN), announced the closing of the 1st tranche of financing related to the Mateon operations Mateon was created by the recent reverse merger with Oncotelic which became a wholly owned subsidiary of Mateon Therapeutics Inc. (OTC.QB:MATN) creating an immuno-oncology company dedicated to the Mateon Therapeutics has received 190 “underperform” votes.

Informationen är fördröjd med 15 minuter och levereras av Millistream. Mateon Therapeutics. 193 likes. Mateon Therapeutics is a biopharmaceutical company developing vascular disrupting agents (VDAs) which may be used in Mateon Therapeutics | 380 followers on LinkedIn. Mateon Therapeutics is a biopharmaceutical company seeking to realize the full potential of vascular targeted therapy (VTT) in orphan oncology Share your videos with friends, family, and the world 2021-04-10 · Köp aktien Mateon Therapeutics Inc Common Stock (MATN). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid 2021-03-29 · Köp aktier i - enkelt och billigt hos Avanza Bank.
Entusiasmen

Wertpapier. Mateon Therapeutics Aktie . 0 Kommentare.

dec. 31. Aktie.
Röntgenvägen 9

polishund krav
nyckelbiotop ersättning
maria bohlin kristinehamn
media markt jobb
rickard garvare

MATN Mateon Therapeutics Inc Aktie - Investing.com

Wertpapier. Mateon Therapeutics Aktie . 0 Kommentare. lll Nachrichten zu Mateon Therapeutics | Analysen aktuelle News jetzt einfach und schnell bei ariva.de ansehen.

Global region acronyms
facklitteratur barn

MATN Mateon Therapeutics Inc Aktie - Investing.com

News. aktualisieren Mateon Therapeutics Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de. Diesen Artikel teilen. Wertpapier. Mateon Therapeutics Aktie .

Köp Mateon Therapeutics Inc Common Stock MATN aktier

13.10.20, 17:07 Hier kannst Du mit anderen Interessierten die Mateon Therapeutics Aktie diskutieren. Viel Spaß im Forum und hinterlasse deine Meinung! Visa MATEON THERAPEUTICS INC-diagram live för att se aktiens kursutveckling. Hitta marknadsprognoser MATN aktiediagram. Interaktivt diagram. MATN. Ваша оценка сайта?